SERELYS
LIVE

Serial Number

79325720

Owner

S.A.M. AXEEN PHARMA

Filing Date

Aug 2, 2021

Add to watchlist:

No watchlists yet
View on USPTO

SERELYS Trademark

Serial Number: 79325720 • Registration: 6988004

SERELYS is a trademark filed by S.A.M. AXEEN PHARMA on August 2, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods). The application is currently registered and active.

Owner Contact Info

S.A.M. AXEEN PHARMA (8 trademarks)

Immeuble Le Triton,

Entity Type: 98

S.A.R.L. AXEEN PHARMA (6 trademarks)

Immeuble Le Triton,

Entity Type: 99

S.A.M. Sérélys Pharma

Immeuble Le Triton,

Entity Type: 99

Trademark Details

Filing Date

August 2, 2021

Registration Date

February 28, 2023

Published for Opposition

December 13, 2022

Goods & Services

Pollen prepared as foodstuff

Pharmaceutical preparations for the treatment of hot flashes, bladder functioning, immune system, fatigue, nervousness, premenstrual and menstrual pain, bone problems, heart problems and vitality problems, and discomfort during perimenopause and menopause; food supplements; nutritional supplements; dietetic substances adapted for medical use, namely, dietetic preparations adapted for medical purposes; food supplements for human consumption in the form of tablets and capsules; pharmaceutical products for the treatment of hot flashes, bladder functioning, immune system, fatigue, nervousness, premenstrual and menstrual pain, bone problems, heart problems and vitality problems, and discomfort during perimenopause and menopause for human use in the form of tablets and capsules; pollen extracts and plant extracts sold as components of food supplements and pharmaceutical preparations for the treatment of hot flashes, bladder functioning, immune system, fatigue, nervousness, premenstrual and menstrual pain, bone problems, heart problems and vitality problems, and discomfort during perimenopause and menopause; pollen dietary supplements and pollen dietary supplements in the form of pollen extracts for medical, pharmaceutical or nutritional use

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Nov 28, 2024 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 26, 2023 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Jun 1, 2023 XXSS
GENERIC MADRID TRANSACTION CREATED
Jun 1, 2023 XXCR
CHANGE OF OWNER RECEIVED FROM IB
May 28, 2023 CHLD
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 28, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 28, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 28, 2023 R.PR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 23, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 23, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 23, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 23, 2022 REAP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 13, 2022 NPUB
PUBLISHED FOR OPPOSITION
Dec 13, 2022 PUBO
NOTIFICATION PROCESSED BY IB
Dec 12, 2022 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 23, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 23, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 23, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 7, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 3, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 2, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 2, 2022 TROA
REFUSAL PROCESSED BY IB
Jul 5, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 11, 2022 RFCS
REFUSAL PROCESSED BY MPU
Jun 11, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 7, 2022 RFCR
NON-FINAL ACTION WRITTEN
May 6, 2022 CNRT
ASSIGNED TO EXAMINER
Apr 29, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 23, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 19, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 18, 2021 REPR